Lead Exposure and Prevention Advisory Committee (LEPAC), 59790-59791 [2022-21405]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
59790
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
for submitting comments to a federal
advisory committee is different from the
process used to submit comments to an
EPA program office. Federal advisory
committees and panels, including
scientific advisory committees, provide
independent advice to the EPA.
Members of the public can submit
relevant comments pertaining to the
committee’s charge or meeting
materials. Input from the public to the
SAB will have the most impact if it
provides specific scientific or technical
information or analysis for the SAB to
consider or if it relates to the clarity or
accuracy of the technical information.
Members of the public wishing to
provide comment should follow the
instruction below to submit comments.
Oral Statements: Individuals or
groups requesting an oral presentation
during the public meeting will be
limited to three minutes. Each person
making an oral statement should
consider providing written comments as
well as their oral statement so that the
points presented orally can be expanded
upon in writing. Persons interested in
providing oral statements should
contact the DFO, in writing (preferably
via email) at the contact information
noted above by October 25, 2022, to be
placed on the list of registered speakers.
Written Statements: Written
statements will be accepted throughout
the advisory process; however, for
timely consideration by SAB members,
statements should be submitted to the
DFO by October 25, 2022, for
consideration at the public meeting on
November 3, 2022, and November 4,
2022. Written statements should be
supplied to the DFO at the contact
information above via email. Submitters
are requested to provide a signed and
unsigned version of each document
because the SAB Staff Office does not
publish documents with signatures on
its websites. Members of the public
should be aware that their personal
contact information if included in any
written comments, may be posted to the
SAB website. Copyrighted material will
not be posted without the explicit
permission of the copyright holder.
Accessibility: For information on
access or services for individuals with
disabilities, please contact the DFO, at
the contact information noted above,
preferably at least ten days prior to the
meeting, to give the EPA as much time
as possible to process your request.
V Khanna Johnston,
Deputy Director, Science Advisory Board Staff
Office.
[FR Doc. 2022–21411 Filed 9–30–22; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
19:00 Sep 30, 2022
Jkt 259001
FARM CREDIT SYSTEM INSURANCE
CORPORATION
Board of Directors Meeting
Notice of the forthcoming
regular meeting of the Board of Directors
of the Farm Credit System Insurance
Corporation (FCSIC), is hereby given in
accordance with the provisions of
article VI of the Bylaws of the FCSIC.
DATES: 10 a.m., Wednesday, October 12,
2022.
ADDRESSES: The public may only
virtually attend the open portions of this
meeting. If you would like to virtually
attend, at least 24 hours in advance,
visit FCSIC.gov, select ‘‘News & Events,’’
then select ‘‘Board Meetings.’’ From
there, access the linked ‘‘Instructions for
board meeting visitors’’ and complete
the described registration process.
FOR FURTHER INFORMATION CONTACT: If
you need more information or assistance
for accessibility reasons, or have
questions, contact Ashley Waldron,
Secretary to the Board. Telephone: 703–
883–4009. TTY: 703–883–4056.
SUPPLEMENTARY INFORMATION: Parts of
this meeting will be open to the public.
The rest of the meeting will be closed
to the public. The following matters will
be considered:
SUMMARY:
Portions Open to the Public
• Approval of June 8, 2022, Minutes
• Quarterly FCSIC Financial Reports
• Quarterly Report on Insured
Obligations
• Quarterly Report on Annual
Performance Plan
• Annual Performance Plan
• Budget 2023–2024
Portions Closed to the Public
• Quarterly Report on Insurance Risk
Ashley Waldron,
Secretary to the Board.
[FR Doc. 2022–21351 Filed 9–30–22; 8:45 am]
BILLING CODE 6705–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
SUMMARY:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
CDC announces the following meeting
for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a
virtual meeting and is open to the
public. Advance registration by
November 23, 2022, is needed to receive
the information to join the meeting. The
registration link is provided in the
addresses section below.
DATES: The meeting will be held on
December 8, 2022, from 11 a.m. to 4
p.m., EST.
ADDRESSES: Register in advance at
https://www.zoomgov.com/webinar/
register/WN_
ym5vFX3dQVuh1spo5SWziQ to receive
information to join the meeting.
FOR FURTHER INFORMATION CONTACT: Paul
Allwood, Ph.D., M.P.H., Designated
Federal Officer, National Center for
Environmental Health, CDC, 4770
Buford Highway, Atlanta, Georgia
30341, Telephone: 770–488–6774;
Email: LEPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and
Prevention Advisory Committee was
established under Section 2203 of
Public Law 114–322, the Water
Infrastructure Improvements for the
Nation Act; 42 U.S.C. 300j–27, Registry
for Lead Exposure and Prevention
Advisory Committee.
Purpose: The LEPAC is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), and the
Director, CDC and Administrator,
ATSDR, on (1) reviewing Federal
programs and services available to
individual communities exposed to
lead; (2) reviewing current research on
lead exposure to identify additional
research needs; (3) reviewing and
identifying best practices, or the need
for best practices regarding lead
screening and the prevention of lead
poisoning; (4) identifying effective
services, including services relating to
healthcare, education, and nutrition for
individuals and communities affected
by lead exposure and lead poisoning,
including in consultation with, as
appropriate, the lead exposure registry
as established in section 2203 (b) of
Public Law 114–322; and (5)
undertaking any other review or
activities that the Secretary determines
to be appropriate.
Matters To Be Considered: The agenda
will include presentations from school
health organizations, healthy housing
organizations, and U.S. Environmental
Protection Agency (EPA) on lead in
schools and discussions on these topics.
Agenda items are subject to change as
priorities dictate.
E:\FR\FM\03OCN1.SGM
03OCN1
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
Public Participation
Oral Public Comment: The public
comment period is scheduled on
December 8, 2022, from 12 p.m. until
12:15 p.m., EST. Individuals wishing to
make a comment during the public
comment period, please email your
name, organization, and phone number
by November 23, 2022, to LEPAC@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–21405 Filed 9–30–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1265; Docket No. CDC–2022–
0121]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled the Chronic
Disease Self-Management
Questionnaire. The questionnaire used
for this study will assess Chronic
Disease Self-Management participant
health behaviors and overall health
before and after a six-week workshop.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:00 Sep 30, 2022
CDC must receive written
comments on or before December 2,
2022.
DATES:
Jkt 259001
You may submit comments,
identified by Docket No. CDC–2022–
0121 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
ADDRESSES:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
59791
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of the Chronic Disease
Self-Management Program in the US
Affiliated Pacific Islands (OMB Control
No. 0920–1265, Exp. 06/30/2021)—
Reinstatement—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
NCCDPHP is evaluating the
implementation of Stanford University’s
Chronic Disease Self-Management
Program (CDSMP) in the U.S. Affiliated
Pacific Islands (USAPI). These
jurisdictions include American Samoa,
Guam, the Commonwealth of the
Northern Mariana Islands, the Republic
of Palau, the Republic of the Marshall
Islands, and the Federated States of
Micronesia.
The purpose of the evaluation is: (1)
to understand how CDSMP is being
implemented in the region; (2) to
identify barriers and facilitators to
implementation; (3) to monitor fidelity
to Stanford University’s model and
document adaptations to the
curriculum; and (4) to understand the
self-reported effects of CDSMP on
program participants. Because this is the
first time CDSMP is being implemented
in the USAPI, we do not know if the
intervention, which has proven to
improve health outcomes in many
ethnic groups within the United States,
will lead to improved health outcomes
for these communities. Collecting this
data helps CDC to assess fidelity to and
adaptations to the intervention, and to
understand if CDSMP, an evidencebased intervention, has the same effect
in the U.S. Affiliated Pacific Islands as
it has in multiple ethnic groups within
the United States.
CDC requests OMB approval for an
estimated 95 annual burden hours.
There are no costs to respondents other
than their time to participate.
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Pages 59790-59791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21405]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee (LEPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a virtual meeting and is open to
the public. Advance registration by November 23, 2022, is needed to
receive the information to join the meeting. The registration link is
provided in the addresses section below.
DATES: The meeting will be held on December 8, 2022, from 11 a.m. to 4
p.m., EST.
ADDRESSES: Register in advance at https://www.zoomgov.com/webinar/register/WN_ym5vFX3dQVuh1spo5SWziQ to receive information to join the
meeting.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H.,
Designated Federal Officer, National Center for Environmental Health,
CDC, 4770 Buford Highway, Atlanta, Georgia 30341, Telephone: 770-488-
6774; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27,
Registry for Lead Exposure and Prevention Advisory Committee.
Purpose: The LEPAC is charged with providing advice and guidance to
the Secretary, Department of Health and Human Services (HHS), and the
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal
programs and services available to individual communities exposed to
lead; (2) reviewing current research on lead exposure to identify
additional research needs; (3) reviewing and identifying best
practices, or the need for best practices regarding lead screening and
the prevention of lead poisoning; (4) identifying effective services,
including services relating to healthcare, education, and nutrition for
individuals and communities affected by lead exposure and lead
poisoning, including in consultation with, as appropriate, the lead
exposure registry as established in section 2203 (b) of Public Law 114-
322; and (5) undertaking any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda will include presentations
from school health organizations, healthy housing organizations, and
U.S. Environmental Protection Agency (EPA) on lead in schools and
discussions on these topics. Agenda items are subject to change as
priorities dictate.
[[Page 59791]]
Public Participation
Oral Public Comment: The public comment period is scheduled on
December 8, 2022, from 12 p.m. until 12:15 p.m., EST. Individuals
wishing to make a comment during the public comment period, please
email your name, organization, and phone number by November 23, 2022,
to [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-21405 Filed 9-30-22; 8:45 am]
BILLING CODE 4163-18-P
